CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Redwood Green Corporation

Redwood Green Corp. delivers high-quality, safe, sustainable, innovative and accessible cannabis-derived products that support individual well-being. Safety and high quality is a critical commitment from Redwood Green, both for our own brands as well as the partners with whom we do business. The drive behind what we do is rooted in improving well-being and quality of life for a wide range of audiences, ensuring we grow and improve upon what is currently available for consumers in the cannabinoids market. The company is publicly traded and listed on the OTC as RDGC.

URAC

URAC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

RxAlly

RxAlly was developed to provide a new solution to the critical issues of providing additional access to care and ensuring effective health care spending at a time when prescription medicine misuse is associated with $290 billion in annual costs. The RxAlly network of pharmacies aims to improve patient health through enhanced pharmacist care that combines clinical research, evidence-based clinical services and an interoperable technology platform.

Cancer Expert Now

Cancer Expert Now`s services connect you to distinguished experts to discuss current disease challenges, recent literature, global clinical findings, and even share their research and experience in the context of your specific diagnosis, or patient cases.

HealthPlan Services

HealthPlan Services (HPS) is the nation’s largest independent provider of sales, benefits administration, retention, reform and technology solutions to the insurance and managed care industries. Headquartered in Tampa, Florida, HPS was founded in 1970 and employs 1,500+ associates. HPS stands at the forefront of the insurance industry, providing exchange connectivity, administration, distribution and technology services to insurers of individual, small group, voluntary and association plans, as well as valuable solutions to thousands of brokers and agents, nationwide. Our Go-To-Exchange® platform combines the services of ExchangeLink, SalesLink, ServiceLink and LoyaltyLink products to enable the connectivity, enrollment, reconciliation, eligibility, subsidy and premium billing, member services and renewals for over 5.0 million members, including 2.4 million members on public exchanges and over 1.2 million members on private exchanges. HPS connects 6 of the nation’s largest insurers to public and state exchanges in 39 states and has a market share of 21%.